These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8282787)

  • 21. Conjugated linoleic acid modulation of cell membrane in leukemia cells.
    Agatha G; Voigt A; Kauf E; Zintl F
    Cancer Lett; 2004 Jun; 209(1):87-103. PubMed ID: 15145524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of pravastatin on fatty acid profile of low density lipoprotein in patients with hypercholesterolemia.
    Hong CY; Lin SJ; Chang MS; Chiang BN; Shen PM; Shiao MS
    Prostaglandins Leukot Essent Fatty Acids; 1993 Feb; 48(2):155-8. PubMed ID: 8446653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatty acid metabolism in phorbol ester-differentiating human leukemia cells.
    Cabot MC; Welsh CJ
    Cancer Res; 1981 Dec; 41(12 Pt 1):4910-5. PubMed ID: 7306991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytochrome P-450 induction by clofibrate. Purification and properties of a hepatic cytochrome P-450 relatively specific for the 12- and 11-hydroxylation of dodecanoic acid (lauric acid).
    Gibson GG; Orton TC; Tamburini PP
    Biochem J; 1982 Apr; 203(1):161-8. PubMed ID: 7103935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low density lipoprotein (LDL) from male volunteers stimulated the thromboxane formation by human platelets.
    Beitz J; Panse M; Förster W
    Prostaglandins Leukot Med; 1983 Apr; 10(4):443-8. PubMed ID: 6574527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid separation of lipid classes in high yield and purity using bonded phase columns.
    Kaluzny MA; Duncan LA; Merritt MV; Epps DE
    J Lipid Res; 1985 Jan; 26(1):135-40. PubMed ID: 3973509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low density lipoproteins of male donors decrease prostacyclin (PGI2) and enhance thromboxane (TXA2) release from rat aortas perfused under pulsatile pressure.
    Beitz J; Hoffmann P; Taube C; Beitz A; Förster W
    Biomed Biochim Acta; 1985; 44(11-12):1681-6. PubMed ID: 3911954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholesterol-induced microsomal changes modulate desaturase activities.
    Leikin AI; Brenner RR
    Biochim Biophys Acta; 1987 Dec; 922(3):294-303. PubMed ID: 3689813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lovastatin, an inhibitor of cholesterol synthesis, induces hydroxymethylglutaryl-coenzyme A reductase directly on membranes of expanded smooth endoplasmic reticulum in rat hepatocytes.
    Singer II; Scott S; Kazazis DM; Huff JW
    Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5264-8. PubMed ID: 3293052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo cholesterol removal from liver microsomes induces changes in fatty acid desaturase activities.
    Leikin AI; Brenner RR
    Biochim Biophys Acta; 1988 Nov; 963(2):311-9. PubMed ID: 3196737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes.
    Ziegler-Heitbrock HW; Thiel E; Fütterer A; Herzog V; Wirtz A; Riethmüller G
    Int J Cancer; 1988 Mar; 41(3):456-61. PubMed ID: 3162233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of lipoproteins produced by the human liver cell line, Hep G2, under defined conditions.
    Thrift RN; Forte TM; Cahoon BE; Shore VG
    J Lipid Res; 1986 Mar; 27(3):236-50. PubMed ID: 3016129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiation-induced gene expression in 3T3-L1 preadipocytes. Characterization of a differentially expressed gene encoding stearoyl-CoA desaturase.
    Ntambi JM; Buhrow SA; Kaestner KH; Christy RJ; Sibley E; Kelly TJ; Lane MD
    J Biol Chem; 1988 Nov; 263(33):17291-300. PubMed ID: 2903162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simvastatin influences linoleic acid metabolism.
    van Doormaal JJ; Bos WJ; Muskiet FA; Doorenbos H
    Pharm Weekbl Sci; 1989 Aug; 11(4):134-5. PubMed ID: 2798037
    [No Abstract]   [Full Text] [Related]  

  • 35. Biochemical mechanisms of induction of hepatic peroxisome proliferation.
    Lock EA; Mitchell AM; Elcombe CR
    Annu Rev Pharmacol Toxicol; 1989; 29():145-63. PubMed ID: 2658768
    [No Abstract]   [Full Text] [Related]  

  • 36. A procedure for eliminating interferences in the lowry method of protein determination.
    Rodríguez-Vico F; Martínez-Cayuela M; García-Peregrín E; Ramírez H
    Anal Biochem; 1989 Dec; 183(2):275-8. PubMed ID: 2624316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A critical evaluation of urinary immunoreactive thromboxane: feasibility of its determination as a potential vascular risk indicator.
    Lorenz RL; Uedelhoven WM; Fischer S; Ruetzel A; Weber PC
    Biochim Biophys Acta; 1989 Dec; 993(2-3):259-65. PubMed ID: 2597697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation and characterization of lipoproteins produced by human hepatoma-derived cell lines other than HepG2.
    Forte TM; McCall MR; Knowles BB; Shore VG
    J Lipid Res; 1989 Jun; 30(6):817-29. PubMed ID: 2551986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peroxisome proliferators enhance linoleic acid metabolism in rat liver. Increased biosynthesis of omega 6 polyunsaturated fatty acids.
    Kawashima Y; Musoh K; Kozuka H
    J Biol Chem; 1990 Jun; 265(16):9170-5. PubMed ID: 2160962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hep G2 cells as a resource for metabolic studies: lipoprotein, cholesterol, and bile acids.
    Javitt NB
    FASEB J; 1990 Feb; 4(2):161-8. PubMed ID: 2153592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.